Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients
Conditions
- Colorectal Cancer
- RAS and BRAF Wild-type
- Colorectal Neoplasms
- Intestinal Neoplasms
- Gastrointestinal Neoplasms
- Digestive System Neoplasms
- Neoplasms by Site
- Neoplasms
- Digestive System Diseases
- Gastrointestinal Diseases
- Colonic Diseases
- Intestinal Diseases
- Rectal Diseases
Interventions
- DRUG: Anlotinib Hydrochloride
- DRUG: Capecitabine
- DRUG: Oxaliplatin
Sponsor
Zhejiang University
Collaborators